We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Statpro Group Plc | LSE:SOG | London | Ordinary Share | GB0006300213 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 236.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/7/2010 14:44 | That's a very interesting point, Geovest. I must admit, despite seeing Revolution as a potentially extremely lucrative kicker on top of the solid core business, I hadn't spotted the sales channel through signed-up custodian banks. This will be an interested story to watch! | courant | |
26/7/2010 10:12 | The key to gaining large volume sales quickly are the custodian banks who already use Statpro 7. The will effectively act as re-sellers to their clients, the smaller fund managers, as this provides seamless integration between font-office (Statpro revolution) and back office (Statpro 7). One global custodian bank has already signed up for a paid integration test -see recent announcement. Statpro traditionally targetted the top 1000 asset managers, but including Revolution, they can now target 30,000 fund managers with investable assets of $500m+. This could become huge. | geovest | |
26/7/2010 08:23 | pentangle - a business doesn't just come up with an idea and hope clients like it, they will have involved key customers in the development process from the off. S | smarm | |
23/7/2010 15:16 | I have been playing around with Statpro Revolution this afternoon. A couple of hiccups setting up my trial as I could not log in initially but that was sorted by the nice Statpro lady. It is a very neat system of portfolio analysis. Basically you plug in your portfolio, which can be imported or put in manually, and you can then analyse it in various ways and against a huge array of benchmarks. I imagine its strengths are ease of use, and the huge number of securities it covers - over 500,000 worldwide plus 9,000 benchmarks. Of course, being internet based, there is no software installation to bother with. There is a lot of portfolio analysis software out there so it remains to be seen how Revolution measures up against the competition. At a quoted price of 'from $100 a portfolio a month' it will be small change for fund managers provided it does prove to be the system they want. Time will tell........ | pentangle | |
23/7/2010 08:57 | Personally I will be a bit disappointed if they come in at 8.5p. Edison was forecasting 9.7p in March and even the HB Markets website has the forecast at 9.0p. | pentangle | |
23/7/2010 08:15 | Per HB: StatPro (SOG, 103.5p, £62.54m) StatPro (SOG, 103.5p, £62.54m) announces the beta launch of StatPro Revolution, its Software as a Service Product (SaaS). The SaaS platform should reduce costs, complexities and broaden the company's target market to smaller fund managers. The high level of recurring revenues provides us with confidence the group will achieve FY expectations of PBT of £7.0m and EPS of 8.5p. The company benefits from high earnings and cash visibility combined with the good growth prospects. We reiterate our BUY recommendation with a target price 127p. (Amisha Chohan) Recommendation: BUY | kimball808 | |
22/7/2010 11:56 | Signed up for the free Statpro Revolution beta test. Be interesting to see what we are investing in! Will report back in due course if they give me access. | pentangle | |
15/7/2010 11:07 | The business looks to be making solid progress. Until earnings start meaningfully growing again, then expansion in PER multiple is unlikely to occur. Like a lot of decent companies, extra patience could be well rewarded. | eagle eye | |
15/7/2010 09:54 | The comforting thing is that with Wheatley sitting on an 11% stake and other Directors having worthwhile holdings, you do feel that their interests are aligned with those of other shareholders when it comes to the end game. Unlike companies where the Directors have negligible share interests. Impressive list of fund managers clearly see value here too. | pentangle | |
15/7/2010 09:28 | Alternatively, because a large part of earnings are generated from the US/Canada, they may go for a Nasdaq listing in a few years time, which would probably value them on a PE of 30 - 40. | geovest | |
15/7/2010 09:06 | Looking back I have held these since June 2005, but have increased my holding recently, and its now my biggest holding. I think that for a company of this quality with high visibility of earnings and good growth prospects, a prospective PER of about 10 is just way too low. I know this business model very well and some years ago was involved in selling a similar business (same model, different industry), albeit earlier stage, for a price which was 20 times current year EBIDTA and over 6 times turnover! Statpro would be a nice bolt on for quite a few larger companies, so I would not be surprised if that was the eventual outcome. | pentangle | |
15/7/2010 06:34 | It is just Wheatley being cautious - he'd rather under-promise and over-deliver. Remember, 2011 forecasts contain £0 revenue from Statpro Revolution and given the signed integration project with a major custodian bank (this is much earlier than expected) and other interest in the beta version should result in a sustantial revenue contribution next year. 2011 will be very exciting. | geovest | |
15/7/2010 06:15 | Trading statement out: Highlights · Trading in H1 in line with expectations · Paid integration test for StatPro Revolution with major global custodian bank · Increasing investment in StatPro Revolution · Net debt reduced to £6.3 million (£8.9 million at 31 December 2009) · Confident of successful outcome to the year Some caution about lengthening sales cycles and a further £700k going into Statpro Revolution, but generally positive. | pentangle | |
12/7/2010 12:02 | Last year we got a half year trading update on 14th July ahead of the interim results on 5th August. So hopefully we could be getting an announcement this week. The AGM statement in May sounded confident enough. | pentangle | |
22/6/2010 06:52 | The hourly fees may be similar but over time audits 'fat out' with number of hours spent. Re-tendering force them to re-evaluate audit program and time spent resulting in savings of typically 25-40%. | geovest | |
21/6/2010 19:10 | agreed..but these are two of the city big guns....prices are surely to be quite similar... | kimball808 | |
21/6/2010 06:44 | Re-tendering professional services such as audit fees very often produce substantial cost saving. | geovest | |
18/6/2010 15:11 | Would be interesting to know the reason for the change...from Price Waterhouse to Ernest & Young...hardly a savings factor involved??? | kimball808 | |
08/6/2010 19:34 | Lets hope that J Wheatley has found the end to this decline...quite a sizeable purchase in the current climate. | kimball808 | |
04/6/2010 12:44 | Not exactly the most encouraging 30 day price trend is it! | ben gunn | |
08/4/2010 10:58 | I really like this share and will buy more if I can get an offer around 126 | 5lowpoke | |
22/3/2010 16:01 | asph Sorry to take so long to get back to you OT EHP was not on my radar, though I am keen on pharmaceuticals and have 2 holdings and 4 on my shortlist. My two holdings ABC and IDH have been absolutely brilliant for me so I am always keen on pharmas as they are also very good defensively in these times. Pharmas have outperformed most other sectors. I like biotechnology and the revenue increases at EHP are impressive though I think they are a bit off being seriously profitable and I now really only buy stocks already showing profitability. With pharmas, cash is king and I see there is £5.5m at the end of last accounts year which seems solid enough. Yes like it - but not yet for me, though it is now added to my watchlist. Good luck with it. Statpro? Where is everyone here? This has been such a good stock I am amzed it is generating so little discussion. Looks a good one to be in. | greek islander | |
15/3/2010 11:34 | Greek Islander Have looked at your suggestions -Thanks. Perhaps you will take a look at EHP hardly any activity on this Board and not being recognised, when I think this is one with merit. I shall be pleased to have your thoughts | asph |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions